glp-1 microdosing for menopause THE PCCA BLOG Why GLP-1s Are a Game
Description
Wegovy is a GLP-1 weight loss medication and it is unlikely to cause diverticulitis
2009 Jan 27;106(4):1285-90
As of July 1, medicare will make certain GLP-1 medications available to those on part d (Medicare) for the treatment of obesity and weight loss at a $50 copay
If policymakers want to expand GLP-1 coverage to include the obesity indication in Medicare, Medicaid, or the commercial insurance sector, theyll need a strategy for managing utilization and targeting populations most likely to benefit
Expect 1015% on orforglipron, 1415% on injectable semaglutide, and 1820% on tirzepatide if you take the drug consistently at target dose with lifestyle support
10.1016/j.jacc.2022.08.738
